ENZY Enzymatica AB (publ)

0.2234USD2.270 SEK · STO-5.42%Mkt Cap: 54.24M USDP/E: —

Enzymatica AB (publ), a life science company, develops and sells medical devices for infectious diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that ca…

Institutional holders2 on file

Key Statistics

Company
Market Cap54.24M USD
Enterprise Value54.94M USD
Revenue (TTM)5.07M USD
Gross Profit3.26M USD
Net Income (TTM)-5.11M USD
Revenue/Share0.02 USD
Last Price0.2234 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees17
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0003943620
Valuation
P/E (Trailing)—
P/E (Forward)-7.57
PEG—
EV/EBITDA-14.69
EV/Revenue10.84
P/S10.70
P/B5.87
EPS (TTM)-0.02 USD
EPS (Forward)-0.03 USD
52W Range
0.152639% of range0.3347
52W High0.3347 USD
52W Low0.1526 USD
Profitability
Gross Margin61.45%
Oper. Margin-78.33%
EBITDA Margin-73.81%
Profit Margin-96.27%
ROE-41.79%
ROA-36.55%
ROIC-55.80%
ROCE-41.37%
Growth
Revenue Growth-2.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.03M USD
CapEx (TTM)22.74K USD
FCF Margin-36.37%
FCF Yield-3.40%
Net Debt699.74K USD
Net Debt/EBITDA-0.19
Net Debt/FCF—
Balance Sheet
Debt/Equity0.01
Current Ratio3.74
Quick Ratio2.32
Book Value/Sh0.04 USD
Cash/Share0.0028 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.242.74M
Float175.75M
Insiders62.70%
Institutions9.85%
Technical
SMA 500.1962 (+13.9%)
SMA 2000.2205 (+1.3%)
Beta-0.55
S&P 52W Chg12.00%
Avg Vol (30d)147.36K
Avg Vol (10d)106.22K
Technical Indicators
RSI (14)51.7
MACD0.1205
MACD Signal0.1400
MACD Hist.-0.0194
BB Upper0.2631 USD
BB Middle0.2267 USD
BB Lower0.1903 USD
BB Width32.09%
ATR (14)0.0162 USD
Vol Ratio (20d)0.62x

About Enzymatica (STO: ENZY)

›

Enzymatica (STO: ENZY) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 17 employees.

The shares were at 2.270 SEK on 19 November 2026, up 18.2% over 52 weeks. Its 52-week range is 1.550 SEK to 3.400 SEK: the price is 33.2% below the high and 46.5% above the low.

Its market capitalisation is 551.01M SEK.

Enzymatica reports return on equity of -41.8%, an operating margin of -78.3% and revenue down 2.9% year over year.

Its debt exceeds its cash by 7.11M SEK, a debt-to-equity ratio of 0.01. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.